-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U6or+XLtKn58/7lyK38Wq9xEeiebZoDZH6ZTg7GWhjV7TpQOYuyMLvfaGQ/VSL+9 lTggtnW2j4M9bL8k+9Ssgw== 0001140888-08-000041.txt : 20080829 0001140888-08-000041.hdr.sgml : 20080829 20080829163206 ACCESSION NUMBER: 0001140888-08-000041 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080829 DATE AS OF CHANGE: 20080829 GROUP MEMBERS: BLACK BEAR OFFSHORE MASTER FUND, L.P. GROUP MEMBERS: EASTBOURNE CAPITAL MANAGEMENT, L.L.C. GROUP MEMBERS: RICHARD JON BARRRY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-42168 FILM NUMBER: 081049520 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EASTBOURNE CAPITAL MANAGEMENT LLC/CA CENTRAL INDEX KEY: 0001140888 IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 1101 FIFTH AVENUE STREET 2: SUITE 370 CITY: SAN RAFAEL STATE: CA ZIP: 94901 BUSINESS PHONE: 4154481200 MAIL ADDRESS: STREET 1: 1101 FIFTH AVENUE STREET 2: SUITE 370 CITY: SAN RAFAEL STATE: CA ZIP: 94901 SC 13D 1 form13d.htm form13d.htm

SEC 1746
(2-98)
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
       OMB APPROVAL
OMB Number:3235-0145
Expires: February 28, 2009
Estimated average burden
hours per response . . . .14.5

 
SCHEDULE 13D
 

 
Under the Securities Exchange Act of 1934
 

 

Amylin Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

032346108

(CUSIP Number)

Eric Sippel
Eastbourne Capital Management, L.L.C.
1101 Fifth Avenue, Suite 370
San Rafael, CA  94901

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

August 29, 2008

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 140.13d-1(g), check the following box.  [X]
 
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See section 240.13d-7 for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a Filer's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

 
 

 
Schedule 13D Page  2 of 9
CUSIP No. 032346108





 
1.
Names of Filers. I.R.S. Identification Nos. of above persons (entities only).
 

 
 
Eastbourne Capital Management, L.L.C.
 


 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
 
 
(a)
__X__
 
 
(b)
______
 


 
3.
SEC Use Only
 
 


 
4.
Source of Funds (See Instructions) 
__AF__
 


 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ____
 


 
6.
Citizenship or Place of Organization 
Delaware
 
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
7.           Sole Voting Power                                                      0
 
8.           Shared Voting Power                                                      17,200,000
9.           Sole Dispositive Power                                                                0
10.           Shared Dispositive Power                                                      17,200,000

 
11.
Aggregate Amount Beneficially Owned by Each Filer17,200,000
 


 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
 
 
Instructions)______
 


 
13.
Percent of Class Represented by Amount in Row (11) 
12.5%
 


 
14.
Type of Filer (See Instructions) 
IA, OO
 


 
 

 
Schedule 13D Page  3 of 9
CUSIP No. 032346108





 
1.
Names of Filers. I.R.S. Identification Nos. of above persons (entities only).
 

 
 
Richard Jon Barry
 


 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
 
 
(a)
__X__
 
 
(b)
______
 


 
3.
SEC Use Only
 
 


 
4.
Source of Funds (See Instructions) 
__AF__
 


 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ____
 


 
6.
Citizenship or Place of Organization 
U.S.A.
 
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
7.           Sole Voting Power                                                      0
 
8.           Shared Voting Power                                                      17,200,000
9.           Sole Dispositive Power                                                                0
10.           Shared Dispositive Power                                                      17,200,000

 
 
11.
Aggregate Amount Beneficially Owned by Each Filer17,200,000
 

 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
 
 
Instructions)______
 

 
13.
Percent of Class Represented by Amount in Row (11) 
12.5%
 

 
14.
Type of Filer (See Instructions) 
IN, HC
 



 
 

 
Schedule 13D Page  4 of 9
CUSIP No. 032346108





 
1.
Names of Filers. I.R.S. Identification Nos. of above persons (entities only).
 

 
 
Black Bear Offshore Master Fund, L.P.
 


 
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
 
 
(a)
______
 
 
(b)
__X__
 


 
3.
SEC Use Only
 
 


 
4.
Source of Funds (See Instructions) 
__WC__
 


 
5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ____
 


 
6.
Citizenship or Place of Organization 
Cayman Islands
 
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
7.           Sole Voting Power                                                      0
 
8.           Shared Voting Power                                                      12,116,463
9.           Sole Dispositive Power                                                                0
10.           Shared Dispositive Power                                                      12,116,463

 
11.
Aggregate Amount Beneficially Owned by Each Filer12,116,463
 


 
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
 
 
Instructions)______
 


 
13.
Percent of Class Represented by Amount in Row (11) 
8.8%
 


 
14.
Type of Filer (See Instructions)PN
 
CO
 



 
 

 
Schedule 13D Page  5 of 9
CUSIP No. 032346108



Preamble
 
This Schedule 13D supersedes the Schedule 13G as last amended by Amendment No. 4 filed on April 3, 2008, filed by Eastbourne Capital Management, L.L.C (“Eastbourne”), Richard Jon Barry (“Barry”) and Black Bear Offshore Master Fund, L.P. (the “Offshore Fund” and, collectively  with Eastbourne and Barry, the “Filers”), relating to shares of Common Stock of Amylin Pharmaceuticals, Inc..  This Schedule 13D is being filed because the Filers may no longer qualify to file on Schedule 13G.  See Item 4 below.
 
Item 1.                      Security and Issuer
 
This statement relates to shares of Common Stock (the "Stock") of Amylin Pharmaceuticals, Inc. (the "Issuer").  The principal executive office of the Issuer is located at 9360 Towne Centre Drive, Suite 110, San Diego, CA 92121.
 
Item 2.  Identity and Background
 
 
(a)
Eastbourne, Barry and the Offshore Fund.  The Offshore Fund is filing jointly with the other Filers, but not as a member of a group, and it expressly disclaims membership in a group.
 
 
(b)
The business address of Eastbourne and Mr. Barry is 1101 Fifth Avenue, Suite 370, San Rafael, CA  94901.  The address of the Offshore Fund is c/o CITCO Fund Services (Cayman Islands) Limited, Corporate Centre, West Bay Road, P.O. Box 31106-SMB, Grand Cayman, Cayman Islands.
 
 
(c)
Eastbourne is a registered investment adviser and is the general partner or manager of investment limited partnerships and limited liability companies, including the Offshore Fund.  Eastbourne also is the investment adviser to those partnerships and companies and to other accounts, including the Offshore Fund.  Mr. Barry is the controlling owner and managing member of Eastbourne.
 
 
(d)
During the last five years, none of the Filers has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
 
 
(e)
During the last five years, none of the Filers was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
 
(f)
Please see the cover page for each Filer for the citizenship of that Filer.
 

 
 

 
Schedule 13D Page  6 of 9
CUSIP No. 032346108



Item 3.  Source and Amount of Funds or Other Consideration
 
The source and amount of funds used in purchasing the Stock were as follows:

Purchaser                                   Source of Funds                                        Amount

Eastbourne/Barry                      Funds under Management                      $446,704,819 (1)
Offshore Fund                           Working Capital                                        $312,044,270

(1) Includes the amount used to purchase the shares of Stock beneficially owned by the Offshore Fund.

 
Item 4.                      Purpose of Transaction
 
The Filers acquired their positions in the shares of Stock in the belief that they were undervalued.  In order to increase their ownership position to more than 15% of the outstanding Stock of the Issuer without triggering the Issuer’s Rights Agreement (“poison pill”), the Filers entered into an Agreement, dated as of March 12, 2008, with the Issuer (the “Standstill Agreement”) that, among other things, might be deemed to prohibit the Filer from participating in strategic discussions about the Issuer’s future while the Standstill Agreement was in effect.  The Standstill Agreement automatically terminated pursuant to its terms as of the close of trading on August 27, 2008, the date on which the Filers sold shares of Stock such that the Filers beneficially owned less than 15% of the outstanding Common Stock of the Issuer.  The Standstill Agreement was filed by the Issuer as an exhibit to a Form 8-K filed on March 13, 2008.
 
Now that the Standstill Agreement has terminated, the Filers may have conversations with Issuer’s management and members of the board of directors, and other shareholders, to discuss the Filers’ ideas as to how the Issuer may be able to maximize product sales and development and more generally to enhance shareholder value.  The Filers believe that the Stock is substantially undervalued.
 
Except as set forth in this Item 4, none of the Filers has any present plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of the instructions to Item 4 of Schedule 13D.  The Filers intend to review their investment in the Issuer on a continuing basis. Depending on various factors, the Reporting Persons may in the future, from time to time, dispose of some or all of the securities of the Issuer beneficially owned by them and/or acquire additional securities of the Issuer, in the open market or otherwise, or take any other actions with respect to their investment in the Issuer permitted by law, including any or all of the actions set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D.

 
Item 5.                      Interest in Securities of the Issuer
 
(a), (b) and (d) Each Filer’s beneficial ownership of the Stock on the date of this report is reflected on that Filer’s cover page.  Eastbourne is an investment adviser with the power to invest in, vote and dispose of the Stock on behalf of its clients, including the Offshore Fund, and is deemed to share beneficial ownership of and voting and dispositive power with respect to the shares of Stock beneficially owned by its clients.  Its clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Stock.  Except for the Offshore Fund, no client individually holds more than 5% of the outstanding Stock.  By virtue of its control of the Offshore Fund, Eastbourne is deemed to share beneficial ownership of (and voting and dispositive power with respect to) the shares of Stock beneficially owned by the Offshore Fund.  Mr. Barry is the controlling owner and managing member of Eastbourne.  By virtue of his control of Eastbourne, Mr. Barry is deemed to share beneficial ownership of (and voting and dispositive power with respect to) the shares of Stock beneficially owned by Eastbourne.

Schedule 13D Page  7 of 9 
CUSIP No. 032346108
 
 
(c ) None of the Filers effected any purchases during the past sixty (60) days.  The following table sets forth all sales with respect to the Stock effected during the past sixty (60) days by any of the Filers.  All such sales of Stock were effected in the open market, and the table includes commissions paid in per share prices.
 

 
Name                                                           Date                                       Shares Sold                                     Price Per Share
 
Offshore Fund                                           8/27/2008                                139,142                                           $20.07
 
Offshore Fund                                           8/27/2008                                34,786                                             $20.28
 
Offshore Fund                                           8/27/2008                                481,219                                           $21.05
 
Offshore Fund                                           8/27/2008                                2,716,411                                        $21.23
 
Offshore Fund                                           8/27/2008                                125,450                                           $21.58
 
Offshore Fund                                           8/27/2008                                695,705                                           $21.77
 
Eastbourne and Barry(1)                         8/27/2008                                 60, 858                                            $20.07
 
Eastbourne and Barry(1)                         8/27/2008                                 15,214                                            $20.28
 
Eastbourne and Barry(1)                         8/27/2008                                 210,481                                          $21.05
 
Eastbourne and Barry(1)                         8/27/2008                                 1,188,130                                       $21.23
 
Eastbourne and Barry(1)                         8/27/2008                                 54,871                                            $21.58
 
Eastbourne and Barry(1)                        8/27/2008                                  304,295                                          $21.77
 
(1)  
Sales listed under Eastbourne and Barry excludes the sales listed under Offshore Fund.
 
(e)  Not applicable
 
Item 6.                      Contracts, Arrangement, Understandings or Relationships with Respect to Securities of the Issuer
 
Eastbourne is the general partner of the Offshore Fund and other investment funds pursuant to agreements of limited partnership or limited liability company agreements between Eastbourne and the Offshore Fund and those other funds, respectively.  Eastbourne is the investment adviser to other accounts pursuant to investment management agreements between Eastbourne and each of those other accounts.  Those agreements provide to Eastbourne the authority, among other things, to invest the funds of the Offshore Fund and other clients in the Stock, to vote and dispose of Stock and to file this statement on behalf of the Offshore Fund and those other clients.  Pursuant to those agreements of limited partnership, limited liability company agreements and investment management agreements, Eastbourne is entitled to allocations and fees based on assets under management and realized and unrealized gains.
 


SIGNATURES

After reasonable inquiry and to the best of my knowledge, I certify that the information set forth in this statement is true, complete and correct.

Schedule 13D Page 8 of 9 
CUSIP No. 032346108
 
 
Dated:                      August 29, 2008
 

 
Eastbourne Capital Management, L.L.C.
 
 
By:           
Eric M. Sippel
Chief Operating Officer
 
 
 
Black Bear Offshore Master Fund,  L.P.
By:          Eastbourne Capital Management, L.L.C.
General Partner
 
 
By:          ____________________________________
Eric M. Sippel
Chief Operating Officer
 



____________________________________
Richard J. Barry

 
 

 
Schedule 13D Page  9 of 9 
CUSIP No. 032346108


EXHIBIT A

AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G

The undersigned agree to file jointly with the Securities and Exchange Commission (the "SEC") any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the common stock of Amylin Pharmaceuticals, Inc. or any other issuer.  For that purpose, the undersigned hereby constitute and appoint Eastbourne Capital Management, L.L.C., a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise of the foregoing power, as fully as the undersigned might or could do if personally present.
 
Dated:                      August 29, 2008

Eastbourne Capital Management, L.L.C.
 
 
By:           
Eric M. Sippel
Chief Operating Officer
 
 
 
Black Bear Offshore Master Fund,  L.P.
By:          Eastbourne Capital Management, L.L.C.
General Partner
 
 
By:          ____________________________________
Eric M. Sippel
Chief Operating Officer
 
 
 
 
 
Richard J. Barry
 






 
 

 

-----END PRIVACY-ENHANCED MESSAGE-----